JJC8-088
Chemical compound

JJC8-088 is a chemical compound that acts as a potent and selective antagonist of the sigma-1 receptor. It is primarily used in scientific research to explore the role of sigma receptors in various physiological and pathological processes.
Chemical Properties[edit]
JJC8-088 is a synthetic compound with a complex chemical structure. The molecular formula of JJC8-088 is C22H28FN3O2, and it has a molecular weight of 385.48 g/mol. The compound is characterized by its high affinity for the sigma-1 receptor, which is a chaperone protein involved in modulating ion channels and other cellular processes.
Pharmacology[edit]
JJC8-088 is known for its high selectivity towards the sigma-1 receptor, with minimal activity at other receptor sites. This selectivity makes it a valuable tool in research settings, allowing scientists to study the specific effects of sigma-1 receptor modulation without interference from other receptor systems.
Mechanism of Action[edit]
The sigma-1 receptor is involved in a variety of cellular functions, including calcium signaling, neuroprotection, and modulation of neurotransmitter systems. JJC8-088 binds to the sigma-1 receptor, inhibiting its activity and thereby affecting these cellular processes. This can lead to changes in neuronal excitability, protection against cellular stress, and modulation of pain perception.
Research Applications[edit]
JJC8-088 is used extensively in preclinical research to investigate the role of sigma-1 receptors in various conditions, such as neuropathic pain, depression, and neurodegenerative diseases. By blocking the sigma-1 receptor, researchers can study the potential therapeutic effects of sigma-1 receptor antagonism in these conditions.
Potential Therapeutic Uses[edit]
While JJC8-088 itself is not used clinically, its ability to modulate sigma-1 receptor activity suggests potential therapeutic applications for sigma-1 receptor antagonists in treating conditions like chronic pain, Alzheimer's disease, and schizophrenia.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of JJC8-088 is not fully established. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented. Researchers handling JJC8-088 must follow appropriate safety protocols to minimize exposure and potential risks.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian